Schedule 13G ownership disclosure
MEDI JECT CORP /MN/
Security class unavailable · CUSIP: 036642106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,023,196
- Percent of class
- 7.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000834237-22-004443
- Form type
- SC 13G
- Filer
- ANTARES PHARMA, INC.
- CIK
- CIK 1016169
- Filed
- Feb 01, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership